Behandling med nucleosidanaloger bør seponeres, når hurtigt stigende aminotransferaseniveauer, progressiv hepatomegali eller metabolisk acidosis/ lactacidosis af ukendt ætiologi indtræder.
Treatment with nucleoside analogues should be discontinued when rapidly elevating aminotransferase levels, progressive hepatomegaly or metabolic/ lactic acidosis of unknown aetiology occur.